Merz Pharmaceuticals Announces Approval of Post-stroke Upper Limb Spasticity Indication for Xeomin(R) in the EU

http://www.prnewswire.com/news-releases/merz-pharmaceuticals-announces-approval-of-post-stroke-upper-limb-spasticity-indication-for-xeominr-in-the-eu-70360177.html

Comments are closed.